Patents Assigned to NIRRIN TECHNOLOGIES, INC.
  • Patent number: 12663378
    Abstract: A device for monitoring a bioreactor is designed for in-situ analysis, e.g., by NIR. The device is configured for maintaining a sample detection region in the reactor medium and can include two or more components, at least one of which is fabricated additively. In an example, a light beam propagates along a free space optical path, passes through a thin 3D printed layer and traverses the sample detection region, where it becomes modulated or modified by interactions with analytes present in the bioreactor. The transmitted light reaches and passes through another thin 3D printed layer and is detected by a photodetector, internal to the device. The electrical signal from the photodetector can be directed to an analyzer via electrical connections. The device or a component thereof can be designed for single use applications.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: June 23, 2026
    Assignee: NIRRIN TECHNOLOGIES, INC.
    Inventors: Bryan A. Hassell, David P. Marchessault
  • Patent number: 12546795
    Abstract: A foam sensor device is used for monitoring foam within a vessel. The sensor (e.g. accelerometer) is encapsulated inside a water-tight, sterilizable, shell, which floats on a liquid contained. In one example, the foam sensor device includes an accelerometer for detecting and measuring rotation and movement of the foam sensor device and generates movement data based on the detected movement. During a learning or calibration process, sensor data (e.g., movement data) from the foam sensor device is analyzed and classified using machine learning and/or signal processing methods to extract features indicative of different possible foam statuses, including varying levels of foam, or no foam and generate models for the different statuses. During normal operation, the foam sensor device transmits sensor data to an analyzer containing the pre-calibrated models, which determines whether there is foam or not. Based on the foam status, a pump controller adds anti-foam solution.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: February 10, 2026
    Assignee: Nirrin Technologies, Inc.
    Inventor: Bryan A. Hassell
  • Patent number: 12492994
    Abstract: A method for studying cell viability and protein aggregation involves establishing a Fabry Perot etalon signal within an optical spectroscopic feature, e.g., in the near infrared region. Protein aggregation and cell viability can be reflected by changes observed in the magnitude of the Fourier Transform peaks observed in the frequency or space domain associated with the contrast of the etalon. In short, the presence of viable cells and protein aggregates can degrade the etalon contrast of an etalon window. In some cases, the concentration of cells and monomeric protein can be measured as well.
    Type: Grant
    Filed: June 5, 2024
    Date of Patent: December 9, 2025
    Assignee: Nirrin Technologies, Inc.
    Inventors: Bryan A. Hassell, Walid A. Atia, David P. Marchessault
  • Patent number: 12222279
    Abstract: A flowcell device, including a flow pathway and an optical subassembly, has a flowcell body that is continuous with a sample being analyzed and a temperature controlled surface. The flowcell body can be disposed between a thermalplate, actively regulated by a thermoelectric cooler, and an insulating member. The flowcell device can be employed in a bioreactor monitoring system.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: February 11, 2025
    Assignee: Nirrin Technologies, Inc.
    Inventors: Bryan A. Hassell, Aaron Delahanty
  • Patent number: 12031908
    Abstract: A method for studying cell viability and protein aggregation involves establishing a Fabry Perot etalon signal within an optical spectroscopic feature, e.g., in the near infrared region. Protein aggregation and cell viability can be reflected by changes observed in the magnitude of the Fourier Transform peaks observed in the frequency or space domain associated with the contrast of the etalon. In short, the presence of viable cells and protein aggregates can degrade the etalon contrast of an etalon window. In some cases, the concentration of cells and monomeric protein can be measured as well.
    Type: Grant
    Filed: November 11, 2020
    Date of Patent: July 9, 2024
    Assignee: Nirrin Technologies, Inc.
    Inventors: Bryan A. Hassell, Walid A. Atia, David P. Marchessault
  • Publication number: 20230034379
    Abstract: A device for monitoring a bioreactor is configured for in-situ analysis, e.g., by NIR, without the need for withdrawing a sample into a sample cell or into an ex-situ arrangement. The device can be inserted into a port of the bioreactor and provides a sample detection region defined by an optical element such as a lens and a photodetector. The electrical signal obtained from a photodetector that is part of the device can be directed to an analyzer via a detachable electrical connection.
    Type: Application
    Filed: October 13, 2022
    Publication date: February 2, 2023
    Applicant: Nirrin Technologies, Inc.
    Inventors: Bryan A. Hassell, David P. Marchessault, Christopher R. Saulnier, John C. Ho, Walid A. Atia
  • Patent number: 11499903
    Abstract: A device for monitoring a bioreactor is configured for in-situ analysis, e.g., by NIR, without the need for withdrawing a sample into a sample cell or into an ex-situ arrangement. The device can be inserted into a port of the bioreactor and provides a sample detection region defined by an optical element such as a lens and a photodetector. The electrical signal obtained from a photodetector that is part of the device can be directed to an analyzer via a detachable electrical connection.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: November 15, 2022
    Assignee: NIRRIN TECHNOLOGIES, INC.
    Inventors: Bryan A. Hassell, David P. Marchessault, Christopher R. Saulnier, John C. Ho, Walid A. Atia